Regeneron Pharmaceuticals Inc
REGN
Regeneron Pharmaceuticals Inc News & Analysis
stocks
Contenders in the vaccine race
These stocks could benefit from the race to roll out antibody therapy for covid-19, writes Vikram Barhat.
stocks
Three vaccines capable of US authorisation in 2020
We expect most US adults will be vaccinated in the first half of 2021, writes Morningstar healthcare strategist Karen Andersen.
markets
What a Covid-19 vaccine means for investors
Three new vaccines for coronavirus look poised for emergency use authorisation in the US this autumn. What does that mean for investors?
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,793.40 | 1.40 | -0.02% |
| CAC 40 | 7,935.97 | 24.44 | 0.31% |
| DAX 40 | 23,564.01 | 116.72 | 0.50% |
| Dow JONES (US) | 46,943.35 | 384.88 | 0.83% |
| FTSE 100 | 10,317.69 | 56.54 | 0.55% |
| HKSE | 25,834.02 | 368.42 | 1.45% |
| NASDAQ | 22,397.29 | 291.93 | 1.32% |
| Nikkei 225 | 53,751.15 | 68.46 | -0.13% |
| NZX 50 Index | 13,164.58 | 22.76 | -0.17% |
| S&P 500 | 6,699.90 | 67.71 | 1.02% |
| S&P/ASX 200 | 8,583.40 | 7.80 | 0.09% |
| SSE Composite Index | 4,084.79 | 10.66 | -0.26% |